Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.
Glumac PM, Gallant JP, Shapovalova M, Li Y, Murugan P, Gupta S, Coleman IM, Nelson PS, Dehm SM, LeBeau AM.
Glumac PM, et al. Among authors: shapovalova m.
Clin Cancer Res. 2020 Mar 1;26(5):1054-1064. doi: 10.1158/1078-0432.CCR-19-1659. Epub 2019 Nov 15.
Clin Cancer Res. 2020.
PMID: 31732520
Free PMC article.